2010/06/16

Vaginorm-C

Composition, structure and packing Vaginorm-C 

Vaginal tablets are oval, white to white with light yellow tint. 1 tab. ascorbic acid 250 mg. Excipients: polimethylsiloxan, lactose monohydrate, gipromelloza, magnesium stearate.

Clinico-pharmacological group: The drug, which regulates the balance vaginal microflora.

Pharmacological action Vaginorm-C 

Antiseptic preparations for intravaginal use. Ascorbic acid reduces the pH of the vagina, inhibiting the growth of bacteria and helps to restore and maintain normal values of pH and vaginal flora (Lactobacillus acidophilus, Lactobacillus gasseri).

Thus, with a decrease in pH of the vagina for several days is marked suppression of growth of anaerobic bacteria, as well as the restoration of normal flora (Lactobacillus acidophilus, Lactobacillus gasseri).

Pharmacokinetics Vaginorm-C 

The systemic circulation is found in small quantities. We derive the kidneys.

Statement
chronic or recurrent vaginitis (bacterial vaginosis, nonspecific vaginitis) caused by the anaerobic flora (due to changes in pH of the vagina);
to normalize the disturbed vaginal microflora.

Dosage regimen Vaginorm-C 

Applied vaginally. A vaginal tablet inserted into the vagina while lying on your back with legs slightly bent 1 times / day in the evening before bedtime. The treatment course is 6 days. Possible repeated courses of treatment. If necessary, treatment can extend for a longer period.

Side effect Vaginorm-C 



Allergic reactions: very rare (<1 / 10000) - hypersensitivity reaction to components of the drug. Local reactions: rare (<1 / 100, ≥ 1 / 1000) - burning or itching in the vagina, increased mucous discharge, hyperemia, edema of the vulva. The drug was well tolerated.

Contraindications
vulvovaginitis candidiasis;
Hypersensitivity to the drug's components.

Pregnancy and lactation Vaginorm-C 

Use of the drug during pregnancy and lactation is not contraindicated.

Vaginorm-C 

The drug does not inhibit the growth of the fungal flora of the vagina. Breaks in the application Vaginorma C in connection with mezhtsiklicheskimi or menstruation are not mandatory. Ascorbic acid effect on the results of the determination of glucose in the urine, the content of transaminase, LDH and bilirubin in the blood serum.

Such manifestations as burning and itching can be caused by concomitant asymptomatic fungal infection. Therefore, when these symptoms should be analyzed to exclude fungal infection.

Drug Interactions Vaginorm-C 

Salicylates stimulate the process of elimination of ascorbic acid from the body. Estrogens increase the bioavailability of ascorbic acid. Ascorbic acid reduces the activity of anticoagulants.

Terms and Conditions of storage Vaginorm-C 

The product should be stored out of reach of children, dry place at temperatures not above 25 ° C. Shelf life - 3 years.